Early reports of The Breast Cancer Linkage Consortium estimated a contralateral breast cancer cumulative risk of 50–60% at age 70 years in BRCA1 or BRCA2 mutation carriers (Easton et al, 1995; The Breast Cancer Linkage Consortium, 1999). The gene discussed is BRCA1; the disease is breast carcinoma.